April 04,2007
Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
###
Next Article Previous Article
Recent News
- Wyden Blasts Trump Tariffs on Brazilian Beef, Coffee and Building Materials to Protect Brazil’s Corrupt Ex-President
- Wyden Blasts Trump Tariff Letters: ‘More Trade Taxes, Higher Prices, More Uncertainty.’
- Wyden to USTR: Congress Must Approve Binding Trade Deals
- Wyden, Warren, Gillibrand, and Sanders Demand Answers on Reckless Rollout of AI Tools at Social Security
- Wyden Condemns Passage of Cruel Senate Republican Budget